BTYNB
Product Specifications
UNSPSC Description
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA (IC50=5 μM). BTYNB exhibits selectivity and effectiveness against IMP1-postive cancer cell lines. BTYNB can be used for cancer research[1].
Target Antigen
c-Myc
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/btynb.html
Purity
98.0
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC=C1/N=C/C2=CC=C(S2)Br)N
Molecular Weight
309.18
References & Citations
[1]Lily Mahapatra,et al. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-124447/BTYNB-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-124447/BTYNB-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
304456-62-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal DRAP1 Antibody (PCRP-DRAP1-1A12) [Alexa Fluor 488]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP3-24152AF488 0.1 mL
Mouse Monoclonal DRAP1 Antibody (PCRP-DRAP1-1A12) [Alexa Fluor 488]
Ask
View Details 